NCT01676779View on ClinicalTrials.gov

mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2016

Conditions
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Interventions
BIOLOGICAL

Dendritic cell therapy

Dendritic cell therapy IV and ID

Trial Locations (1)

1090

UZ Brussel, Brussels

All Listed Sponsors
collaborator

RIZIV

UNKNOWN

lead

Universitair Ziekenhuis Brussel

OTHER

NCT01676779 - mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma | Biotech Hunter | Biotech Hunter